Real-world effectiveness and treatment costs of ceftazidime-avibactam versus colistin-meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients.
Kose A, Candas N, Yasar S, Toplu S A, Memisoglu F, Tanriverdi E S, Kocaaslan H, Gunay E
